Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00979940 · ClinicalTrials.gov registry record · NA
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00979940 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 60 participants.
The verdict
NCT00979940, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research study plans to evaluate the use of atorvastatin in patients with coronary artery disease given immediately before PCI and whether it will decrease the amount of heart damage after PCI.
Interventions
- DRUG Atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00979940
The ClinicalTrials.gov registry entry for NCT00979940 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atorvastatin is the first listed.
NCT00979940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00979940 about?
NCT00979940 is a clinical study titled "Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)". This research study plans to evaluate the use of atorvastatin in patients with coronary artery disease given immediately before PCI and whether it will decrease the amount of heart damage after PCI.
What is the current status of trial NCT00979940?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2008-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00979940?
The interventions under investigation include: Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00979940?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.